Prelude Therapeutics Inc
Pharmaceutical company · Wilmington, Delaware, United States · Nasdaq: PRLD
Prelude Therapeutics Inc is a pharmaceutical company headquartered in Wilmington, Delaware, United States. Its earliest recorded incorporation is in 2016. Its shares trade on Nasdaq under the ticker PRLD. It has reported private securities offerings to the US SEC, most recently $50 million sold in a notice filed in 2020.
Prelude Therapeutics at a glance
What does Prelude Therapeutics do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $50 million sold (2020).
Frequently asked questions about Prelude Therapeutics
Where is Prelude Therapeutics headquartered?
Prelude Therapeutics Inc is headquartered in Wilmington, Delaware, United States.
What does Prelude Therapeutics do?
Prelude Therapeutics Inc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Prelude Therapeutics a public company?
Yes. Prelude Therapeutics Inc trades on Nasdaq under the ticker PRLD.
When was Prelude Therapeutics founded?
The earliest incorporation on record for Prelude Therapeutics Inc is in 2016, according to public company registers.
Similar companies
- Dusa Pharmaceuticals IncWilmington, Massachusetts, United States
- NeuroRx, Inc.Wilmington, Delaware, United States
- NRX Pharmaceuticals, Inc.Wilmington, Delaware, United States
- Applied Molecular Transport Inc.Wilmington, Delaware, United States
- ImmunoRx Pharma, Inc.Wilmington, Delaware, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences